Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan
- PMID: 28090007
- PMCID: PMC5600036
- DOI: 10.2463/mrms.cr.2016-0090
Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan
Abstract
The present case is the first report in Japan in which a breast cancer was discovered as a result of prospective magnetic resonance imaging (MRI) screening study for BRCA1/2 mutation carriers who were free of breast or ovarian cancer. This case is significant and it verifies the importance of MRI screening in breast or ovarian cancer-free BRCA1/2 mutation carriers who do not exhibit positive mammographic or ultrasonographic findings.
Keywords: BRCA2; ductal carcinoma in situ; hereditary breast and ovarian cancer syndrome; magnetic resonance imaging.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






References
-
- Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66–71. - PubMed
-
- Ikeda N, Miyoshi Y, Yoneda K, et al. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 2001; 91:83–88. - PubMed
-
- American College of Radiology Breast imaging reporting and data system (BI-RADS). 5th edn Reston, VA; 2013.
-
- Nakamura S, Takahashi M, Tozaki M, et al. Prevalence and differentiation of hereditary breast and ovarian cancers in Japan. Breast Cancer 2015; 22:462–468. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous